Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
The impact of bevacizumab intraperitoneal perfusion combined with paclitaxel and platinum-based chemotherapy on serum stromal-derived factor-1α (SDF-1α) and chemokine ligand 5 (CXCL-5) levels in patients with ovarian cancer after tumor cell debulking surgery.
Anticancer Drugs
January 2025
Oncology gynecology, The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China.
The aim of this study is to investigate the impact of bevacizumab intraperitoneal perfusion combined with paclitaxel and platinum-based chemotherapy on serum stromal-derived factor-1α (SDF-1α) and chemokine ligand 5 (CXCL-5) levels in patients with ovarian cancer after tumor cell debulking surgery. This clinical study was conducted on a cohort of 89 ovarian cancer patients who underwent tumor debulking surgery at our hospital from February 2020 to February 2021. The patients were divided into two groups using a random number table: the control group (n = 44) received postoperative treatment with paclitaxel and platinum-based chemotherapy, while the research group (n = 45) received additional treatment with intraperitoneal perfusion of bevacizumab in addition to the control group's treatment regimen.
View Article and Find Full Text PDFAn Unusual Cause of Inguinal Mass in a Patient with Urolithiasis: A Case Report of Deep (Aggressive) Angiomyxoma in a Male Patient.
Clin Pract
December 2024
Department of Urology, University Hospital of Patras, 26504 Patras, Greece.
Deep or aggressive angiomyxoma is an uncommon neoplasm of the pelvis. Although deep angiomyxoma is a benign tumor, its tendency to infiltrate soft tissues and reach a large size (typically > 10 cm) indicates aggressive biological behavior. It is usually present in female patients, but there have been recent reports of male-aggressive angiomyxoma.
View Article and Find Full Text PDFEpididymo-Orchitis Secondary to Aeromonas hydrophila: A Rare Presentation and Case Report.
Cureus
November 2024
Department of Infection Prevention and Control, King Abdulaziz Medical City, Riyadh, SAU.
is a group of bacteria commonly found in water sources. These bacteria are known to cause gastrointestinal and skin infections, while their association with urinary tract infections is relatively rare. Here, we present a case of epididymitis in a patient with a chronic neurogenic bladder managed with clean intermittent catheterization.
View Article and Find Full Text PDFPreserving one artery shortens the surgical time and does not affect the efficacy of microsurgical subinguinal varicocelectomy: preliminary findings from a retrospective study.
BMC Urol
December 2024
Department of Urology, 920th Hospital of Joint Logistic Support Force, Kunming, 650000, China.
Background: To analyze the safety and efficacy of microsurgical subinguinal varicocelectomy(MSV) performed with and without preservation of all testicular arteries and lymphatic system.
Methods: All of the 98 patients with varicocele who underwent MSV were included in the analysis. Fifty-eight male patients surgically underwent MSV with preservation of all testicular arteries and lymphatic system(Group 1).
[Comparative analysis of the results of treatment of patients with recurrent urethral stricture using platelet-rich plasma].
Urologiia
May 2024
Department of Urology and Andrology, Russian National Research Medical University. N.I. Pirogov, Moscow, Russia.
Introduction: The treatment tactics of patients with recurrent urethral stricture requires an integrated approach. An increase in the treatment efficiency is possible not only through improvements in surgical technique, but also by influencing the pathogenetic mechanisms of the formation of urethral stricture and stimulating regeneration.
Aim: To evaluate the efficiency of reconstructive procedures using platelet-rich plasma in patients with recurrent urethral stricture.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!